Hidradenitis Suppurativa
Hidradenitis Suppurativa (HS) is a chronic skin condition characterized by painful lumps under the skin, often in areas like the armpits and groin. These lumps can become inflamed and lead to abscesses and scarring.
Hidradenitis Suppurativa: Ruxolitinib Cream Study
We are evaluating a new cream for people with hidradenitis suppurativa to see if it helps reduce symptoms and is safe to use. This study aims to find out how effective the cream is compared to a placebo.
What diseases are being studied?
Health conditions and diseases that the clinical trial is designed to study and treat.
Who can participate in the clinical trial?
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
- Are you 12 years old or older?
- Do you have hidradenitis suppurativa (HS) for at least 6 months?
- Are you currently pregnant or breastfeeding?
- Are you taking any systemic medications like steroids or immunosuppressants?
- Have you had any major surgery or trauma in the last 30 days?
Where is the clinical trial being conducted?
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Loading map...
AZ Sint-Lucas & Volkskliniek
Dermatology
Gent, Belgium
UZ Leuven
Dermatology
Heverlee, Belgium
Universitair Ziekenhuis Gent
Dermatology
Ledeberg, Belgium
Sponsor: Incyte Corp.
Last updated: Nov 26, 2025
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.